Vimian Q3 Revenue Rises 15% to €120.3M; Adjusted EBITA €29.2M
Vimian Group reported 11% organic revenue growth and adjusted EBITA at a 24.3% margin, up 14% year over year. After quarter-end, it signed the acquisition of Norfolk Medical Products.
Vimian Group’s Q3 revenue increased 15% year over year to €120.3M, including 11% organic growth. Adjusted EBITA rose 14% year over year to €29.2M, representing a 24.3% margin. After the quarter ended, Vimian signed an agreement to acquire Norfolk Medical Products.